Access to methotrexate in limbo post-Roe — report

On the heels of the Supreme Court’s decision to overturn Roe v. Wade, some women have said they’ve had trouble accessing methotrexate — a common drug for autoimmune diseases and cancer that’s also used off-label to end ectopic pregnancies.

The Lupus Foundation of America confirmed on Monday that it’s aware...

Click to view original post